Close Menu


Additional funding opportunities

Research Funding Opportunities

Tools to Find Funding

Grants Awarded for Health Sciences Research

Title Type $ Amount Activitysort descending Investigator Unit Sponsor Date
Multi-Parametric Optimization of Software Quantification for SPECT Dopamine Transporter Imaging Contract $33,156.00 Clinical Trial Phillip Kuo Medical Imaging GE Healthcare 08/2020
Nitric Oxide Treatment In COVID-19 Evaluation (NOTICE) Contract $18,455.00 Clinical Trial Thomas Ardiles COM Phx Internal Medicine Pharmerit International 01/2021
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Patients with COVID-19 Pneumonia Contract $3,236,387.50 Clinical Trial Sachin Chaudhary Medicine Syneos Health 06/2020
PETAL Network International Coordinating Center for ACTIV-3 Trial Initiative Grant $820,500.00 Clinical Trial Jarrod Mosier Dept of Emergency Medicine Albert Einstein College of Medicine 12/2020
A Master Protocol Assessing the Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Hospitalized Patients with COVID-19 Contract $450,320.00 Clinical Trial Marilyn Glassberg Csete COM Phx Internal Medicine Regeneron Pharmaceuticals, Inc 12/2020
A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants with Previously Treated Locally Advanced/Metastatic or Surgically Unresectable.. Contract $171,440.00 Clinical Trial Aaron Scott Cancer Center Division Incyte Corporation 05/2020
RELIEVE-HF: REducing Lung CongestIon Symptoms Using the V-WavE Shunt in adVancEd Heart Failure Contract $621,878.00 Clinical Trial Nancy Sweitzer Sarver Heart Center V-Wave Ltd. 11/2020
A Randomized Phase 3 Study to Evaluate the Efficacy and Safety of Enzastaurin Plus R-CHOP Versus R-CHOP in Treatment-Naive Subjects with High-Risk Diffuse Large B-Cell Lymphoma Who Possess the Novel.. Contract $327,830.00 Clinical Trial Abhijeet Kumar Cancer Center Division Covance, Incorporated 01/2020
Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI-DTU Trial Contract $113,035.00 Clinical Trial Deepak Acharya Sarver Heart Center ABIOMED, Inc. 08/2020
Passive Immunity Trial for Our Nation (PassItOn): A Randomized, Placebo Controlled Multi-Site Trial of Anti-SARS-CoV-2 Convalescent Plasma to Treat Hospitalized Adults with COVID-19 Contract $504,040.00 Clinical Trial Marilyn Glassberg Csete COM Phx Internal Medicine Vanderbilt University Medical Center 01/2021
A Randomized, Double-blind, Placebo-controlled Clinical Trial of Fluconazole as Early Empiric Treatment of Coccidioidomycosis Pneumonia (Valley Fever) in Adults Presenting with Community Acquired... Contract $593,373.00 Clinical Trial John Galgiani Valley Fever Ctr for Excellnc Duke University 06/2020
A Phase 1b/2 Study of Ibrutinib Combination Therapy in Selected Advanced Gastrointestinal And Genitourinary Tumors Contract $682,977.50 Clinical Trial Edward Gelmann Cancer Center Division Pharmacyclics Incorporated 04/2020
A Phase 1/2 Dose Escalation and Dose Expansion Study of BA3011 in Patients with Advanced Solid Tumors Contract $424,465.24 Clinical Trial Pavani Chalasani Cancer Center Division Covance, Incorporated 09/2020
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of VX-814 in PiZZ Subjects Contract $79,672.00 Clinical Trial Ramachandra Sista COM Phx Internal Medicine Vertex Pharmaceuticals, Incorporated 05/2020
Women's Ischemia Trial to Reduce Events in Non-Obstructive CAD (WARRIOR) Contract $9,190.44 Clinical Trial Nancy Sweitzer Sarver Heart Center University of Florida 11/2020
Phase 3b Study for Evaluation of Efficacy and Nutritional Benefits of Pancrelipase in Patients with Exocrine Pancreatic Insufficiency due to Periampullary and Pancreatic Cancer Contract $122,409.40 Clinical Trial Hani Babiker Cancer Center Division AbbVie Incorporated 01/2020
Prospective, Open-label Study of Andexanet Alfa in Patients Receiving a Factor Xa Inhibitor Who Require Urgent Surgery (Annexa-s) Contract $2,877,732.00 Clinical Trial Patrick Bosarge COM Phx Surgery Portola Pharmaceuticals, Inc. 03/2021
Advancing Liver Therapeutic Approaches (ALTA). The ALTA Consortium Study Group for the management of portal hypertension - A 5-year longitudinal observation study of patients with cirrhosis .... Contract $26,687.50 Clinical Trial Michael Fallon COM Phx Internal Medicine Northwestern University 06/2020
A First-In-Human, Multicenter, Open-Label, Phase 1 Dose Escalation and Cohort Expansion Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TAB004 in Subjects with Advanced Solid Malig Contract $322,513.00 Clinical Trial Daniel Persky Cancer Center Division TopAlliance Biosciences, Inc. 04/2021
Sleep SMART: Sleep for Stroke Management And Recovery Trial Cooperative Agreement $47,916.00 Clinical Trial Joyce Lee-Iannotti COM Phx Neurology University of Cincinnati 04/2020
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects with Idiopathic Pulmonary Fibrosis (IPF) Contract $433,913.00 Clinical Trial Bhupinder Natt Medicine Worldwide Clinical Trials 10/2020
A Phase 3, Randomized, Double- Blinded, Placebo-Controlled Trial To Evaluate the Efficacy and Safety of a Respiratory Syncytial Virus (RSV) Prefusion F Subunit Vaccine in Infants Born to.... Contract $124,499.00 Clinical Trial Mohamed Ahmed Pediatrics Pfizer, Incorporated 05/2020
The MITRAL Trial (Mitral Implantation of TRAnscatheter VaLves is Native Mitral Stenosis) Contract $62,000.00 Clinical Trial Ashish Pershad COM Phx Internal Medicine Mayo Foundation for Medical Education and Research (Mayo Clinic) 01/2020
Expanded Access Program Basis for the Treatment of Relapsed/Refractory Multiple Myeloma Contract $95,540.64 Clinical Trial Krisstina Gowin Cancer Center Division Glaxosmithkline 06/2020
A Multicenter, Adaptive, Randomized Controlled Platform Trial of the Safety and Efficacy of Antithrombotic Strategies in Hospitals Adults with COVID-19 Contract $178,900.00 Clinical Trial Bellal Joseph Surgery New York University 04/2021